Filters: Author is Biskup, Saskia [Clear All Filters]
Andres-Mateos E, Mejias R, Sasaki M, Li X, Lin BM, Biskup S, et al. Unexpected Lack of Hypersensitivity in LRRK2 Knock-Out Mice to MPTP (1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine). J Neurosci. 2009;29(50):15846-50.
0
Biskup S, Gerlach M, Kupsch A, Reichmann H, Riederer P, Vieregge P, et al. Genes associated with Parkinson syndrome. J Neurol. 2008;255 Suppl 5:8-17.
Higashi S, Biskup S, West AB, Trinkaus D, Dawson VL, Faull RL, et al. Localization of Parkinson's disease-associated LRRK2 in normal and pathological human brain. Brain Res. 2007;1155:208-19.
Higashi S, Moore DJ, Colebrooke RE, Biskup S, Dawson VL, Arai H, et al. Expression and localization of Parkinson's disease-associated leucine-rich repeat kinase 2 in the mouse brain. J Neurochem. 2007;100(2):368-81.
Biskup S, Moore DJ, Rea A, Lorenz-Deperieux B, Coombes CE, Dawson VL, et al. Dynamic and redundant regulation of LRRK2 and LRRK1 expression. BMC neuroscience. 2007;8:102.
Biskup S, Moore DJ, Celsi F, Higashi S, West AB, Andrabi SA, et al. Localization of LRRK2 to membranous and vesicular structures in mammalian brain. Ann Neurol. 2006;60(5):557-69.
West AB, Moore DJ, Biskup S, Bugayenko A, Smith WW, Ross CA, et al. Parkinson's disease-associated mutations in leucine-rich repeat kinase 2 augment kinase activity. Proc Natl Acad Sci USA. 2005;102(46):16842-7.
Biskup S, Mueller JC, Sharma M, Lichtner P, Zimprich A, Berg D, et al. Common variants of LRRK2 are not associated with sporadic Parkinson's disease. Ann Neurol. 2005;58(6):905-8.
Zimprich A, Biskup S, Leitner P, Lichtner P, Farrer M, Lincoln S, et al. Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology. Neuron. 2004;44(4):601-7.

]